CD4 T cells and antitumor immunity

Results: 29



#Item
1Anti-tumor activity of PEGylated human IL-10 (AM0010) in patients with Pancreatic or Colorectal Cancer. Kyriakos P. Papadopoulos1*, Aung Naing2*, Jeffrey R. Infante3*, Deborah J. Wong6, Karen A. Autio4, Patrick A. Ott5,

Anti-tumor activity of PEGylated human IL-10 (AM0010) in patients with Pancreatic or Colorectal Cancer. Kyriakos P. Papadopoulos1*, Aung Naing2*, Jeffrey R. Infante3*, Deborah J. Wong6, Karen A. Autio4, Patrick A. Ott5,

Add to Reading List

Source URL: www.armobio.com

Language: English - Date: 2016-06-22 11:57:32
2Presentation SGpptx

Presentation SGpptx

Add to Reading List

Source URL: www.comites-d-interface.inserm.fr

Language: English - Date: 2016-07-05 12:04:24
3PEGylated IL-10 (AM0010) for advanced solid tumors - a Phase 1 study Aung Naing1, Jeffrey R. Infante2, Kyriakos P. Papadopoulos3, Karen A. Autio4, Patrick A. Ott5, Deborah J. Wong6, Gerald S. Falchook7, Manish R. Patel2,

PEGylated IL-10 (AM0010) for advanced solid tumors - a Phase 1 study Aung Naing1, Jeffrey R. Infante2, Kyriakos P. Papadopoulos3, Karen A. Autio4, Patrick A. Ott5, Deborah J. Wong6, Gerald S. Falchook7, Manish R. Patel2,

Add to Reading List

Source URL: www.armobio.com

Language: English - Date: 2015-12-11 00:15:35
4ASCO Annual Meeting - Chicago, IL, May 29 –June 2, 2015; Abstract #3017  Poster #: 343 A first-in-human dose escalation study of PEGylated recombinant human IL-10 (AM0010) in advanced solid tumors. Jeffrey R. Infante1,

ASCO Annual Meeting - Chicago, IL, May 29 –June 2, 2015; Abstract #3017 Poster #: 343 A first-in-human dose escalation study of PEGylated recombinant human IL-10 (AM0010) in advanced solid tumors. Jeffrey R. Infante1,

Add to Reading List

Source URL: www.armobio.com

Language: English - Date: 2015-12-11 00:15:33
5  www.impactaging.com  AGING, June 2015, Vol. 7, No 6 Editorial   

  www.impactaging.com AGING, June 2015, Vol. 7, No 6 Editorial  

Add to Reading List

Source URL: www.impactaging.com

Language: English
6  www.impactaging.com  AGING, June 2015, Vol. 7, No 6 Editorial   

  www.impactaging.com AGING, June 2015, Vol. 7, No 6 Editorial  

Add to Reading List

Source URL: impactaging.com

Language: English
7Award ID: DP150083 Project Title: NKT Cell Platform for Cancer Immunotherapy Award Mechanism: Bridging the Gap: Early Translational Research Awards

Award ID: DP150083 Project Title: NKT Cell Platform for Cancer Immunotherapy Award Mechanism: Bridging the Gap: Early Translational Research Awards

Add to Reading List

Source URL: www.cprit.state.tx.us

Language: English - Date: 2014-11-20 01:49:42
8SUPPLEMENTARY INFORMATION  doi:nature11259 Materials and Methods

SUPPLEMENTARY INFORMATION doi:nature11259 Materials and Methods

Add to Reading List

Source URL: limlab.ucsf.edu

Language: English - Date: 2014-12-24 04:41:37
9Indian J Med Res 141, February 2015, ppEditorial Mesenchymal stromal cells as regulators of anti-tumour immune response  	 in India, breast and cervix uteri cancers are two

Indian J Med Res 141, February 2015, ppEditorial Mesenchymal stromal cells as regulators of anti-tumour immune response in India, breast and cervix uteri cancers are two

Add to Reading List

Source URL: www.icmr.nic.in

Language: English - Date: 2015-04-17 06:59:01
10Principal Research Results  Enhancement of Tumor Rejection in Mice by Low Dose-rate γ Irradiation Background It is known that medicine or alcohol have different biological effects according to the dose. It becomes clear

Principal Research Results Enhancement of Tumor Rejection in Mice by Low Dose-rate γ Irradiation Background It is known that medicine or alcohol have different biological effects according to the dose. It becomes clear

Add to Reading List

Source URL: criepi.denken.or.jp

Language: English - Date: 2008-09-29 03:17:19